Immediate Impact

1 by Nobel laureates 6 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Radiochemistry for positron emission tomography
2023 Standout
2 intermediate papers

Works of Jeanette Watson being referenced

An evaluation of the brain distribution of [11C]GSK1034702, a muscarinic-1 (M1) positive allosteric modulator in the living human brain using positron emission tomography
2014
Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice
2008

Author Peers

Author Last Decade Papers Cites
Jeanette Watson 314 283 38 80 8 494
F. Guilloux 370 217 29 51 8 537
Jean-Pierre Famaey 311 249 28 83 13 540
S.L. Sherwood 249 150 15 63 11 565
Paul F.M. Janssen 363 238 8 95 13 511
Joseph J. Gingell 360 326 51 118 17 517
Eiko Itoga 340 417 34 32 20 570
Val J. Watts 349 238 11 68 9 544
Julia M. Hill 252 263 15 31 6 542
J Mizoule 367 176 11 54 10 537
Shu-Hui Chuang 184 183 23 119 13 424

All Works

Loading papers...

Rankless by CCL
2026